To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene AIPTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
524 supporting clones for gene AIP back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP348117 brain .a 1 to 584 1 to 582   tiling clone,   582/582
(100 %)
4 diff
(99.4 %id)
TI_57177697   .a 8 to 794 30 to 814       785/814
(96 %)
9 diff
(98.9 %id)
BG468963 adenocarcinoma cell line, colon .a 9 to 862 1 to 862       862/862
(100 %)
24 diff
(97.3 %id)
BG821308 adenocarcinoma cell line, colon .a 9 to 715 1 to 707       707/709
(99 %)
1 diff
(99.9 %id)
BI197312 brain, neuroblastoma .a 9 to 920 1 to 910       910/911
(99 %)
44 diff
(95.2 %id)
NM_003977.2   .a 9 to 1240 1 to 1232 exact RefSeq, AAA   1232/1232
(100 %)
0 diff
(100 %id)
BQ226682 embryonal carcinoma, cell line, testis .a 11 to 638 1 to 631       629/984
(63 %)
8 diff
(99.2 %id)
BG328954 eye, retinoblastoma .a 12 to 782 1 to 762       762/817
(93 %)
19 diff
(97.7 %id)
BM468521 melanotic melanoma, skin .a 12 to 863 1 to 854       854/1013
(84 %)
9 diff
(99.2 %id)
BM706937 eye, optic nerve .a 12 to 465 9 to 462       454/462
(98 %)
6 diff
(98.8 %id)
BG329112 eye, retinoblastoma .a 13 to 785 1 to 771       771/901
(85 %)
30 diff
(96.7 %id)
BI766388 pooled lung and spleen .a 13 to 794 1 to 780       780/780
(100 %)
5 diff
(99.4 %id)
BQ425341 eye, retinoblastoma .a 13 to 507 1 to 509       509/806
(63 %)
20 diff
(97.6 %id)
DR155753 human embryonic stem cells differentiated toan early endodermal cell type .a 13 to 785 1 to 772       772/772
(100 %)
1 diff
(99.9 %id)
BF530777 anaplastic oligodendroglioma with 1p/19qloss, brain .a 14 to 789 13 to 785       773/842
(91 %)
23 diff
(97.3 %id)
BI766389 pooled lung and spleen .a 14 to 793 1 to 777       777/778
(99 %)
4 diff
(99.5 %id)
BG575351 breast, mammary adenocarcinoma, cell line .a 15 to 805 1 to 792       792/793
(99 %)
7 diff
(99.2 %id)
TI_57177698   .a 15 to 793 33 to 808       776/809
(95 %)
7 diff
(99.2 %id)
CR998105 T-Lymphocytes .a 15 to 575 1 to 561       561/566
(99 %)
2 diff
(99.7 %id)
TI_154193479   .a 15 to 919 50 to 939       890/1028
(86 %)
21 diff
(98.0 %id)
CR607044 Placenta Cot 25-normalized .a 16 to 1172 1 to 1157 exact tiling clone,   1157/1157
(100 %)
0 diff
(100 %id)
AL550541 placenta, Placenta Cot 25-normalized .a 16 to 443 1 to 427   fully sequenced,   427/427
(100 %)
1 diff
(99.8 %id)
CD674822 eye, lens .a 16 to 654 1 to 639       639/639
(100 %)
1 diff
(99.9 %id)
R10503 liver and spleen .a 16 to 363 1 to 356       356/363
(98 %)
19 diff
(94.8 %id)
BG830689 epithelioid carcinoma cell line, Pancreas .a 16 to 789 1 to 790       790/1017
(77 %)
32 diff
(96.9 %id)
BM473258 duodenal adenocarcinoma, cell line, small intestine .a 16 to 920 1 to 914       914/1013
(90 %)
24 diff
(97.7 %id)
CF127798 Chondrosarcoma Lung Metastasis cell lines, lung .a 16 to 800 1 to 783       783/783
(100 %)
3 diff
(99.7 %id)
AA325369 brain, cerebellum .a 17 to 194 1 to 177       177/177
(100 %)
1 diff
(99.5 %id)
BX331735 Neuroblastoma Cot 25-normalized .a 17 to 1036 1 to 1010       1010/1077
(93 %)
31 diff
(97.2 %id)
CF142285 CNCAP(3)T-225 cell line, Prostate .a 17 to 395 1 to 379       379/379
(100 %)
7 diff
(98.2 %id)
BF307663 muscle, rhabdomyosarcoma .a 17 to 779 1 to 759       759/1108
(68 %)
18 diff
(98.4 %id)
BF343441 brain, glioblastoma with EGFR amplification .a 17 to 776 1 to 756       756/778
(97 %)
13 diff
(98.4 %id)
CD172513 White Matter .a 17 to 863 21 to 870       850/879
(96 %)
10 diff
(98.9 %id)
U78521   .a 17 to 1236 1 to 1220 Q228K Q307R tiling clone, AAA   1220/1220
(100 %)
8 diff
(99.4 %id)
BG912923 anaplastic oligodendroglioma with 1p/19qloss, brain .a 19 to 653 1 to 666       663/671
(98 %)
51 diff
(92.4 %id)
BQ051267 large cell carcinoma, lung .a 19 to 863 1 to 849       849/999
(84 %)
19 diff
(98.1 %id)
CK430631 eye, lacrimal gland .a 20 to 597 1 to 578       578/578
(100 %)
0 diff
(100 %id)
BQ674196 epidermoid carcinoma, cell line, salivary gland .a 21 to 848 1 to 830       830/875
(94 %)
10 diff
(98.9 %id)
BI762174 pooled colon, kidney, stomach .a 22 to 904 1 to 881       881/881
(100 %)
22 diff
(97.6 %id)
BQ673240 epidermoid carcinoma, cell line, salivary gland .a 22 to 920 1 to 907       907/919
(98 %)
26 diff
(97.2 %id)
BQ927863 large cell carcinoma, lung .a 22 to 782 1 to 764       764/938
(81 %)
15 diff
(98.5 %id)
BQ955084 large cell carcinoma, lung .a 22 to 948 1 to 928       928/932
(99 %)
13 diff
(98.7 %id)
CN399894 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 23 to 741 1 to 719       719/719
(100 %)
1 diff
(99.9 %id)
BF348158 anaplastic oligodendroglioma with 1p/19qloss, brain .a 23 to 789 1 to 766       766/990
(77 %)
23 diff
(97.7 %id)
BG029935 breast, mammary adenocarcinoma, cell line .a 23 to 753 13 to 739       727/780
(93 %)
15 diff
(98.1 %id)
BM554857 amelanotic melanoma, cell line, skin .a 23 to 913 28 to 922       895/1067
(83 %)
28 diff
(97.4 %id)
BQ723288 sympathetic trunk .a 23 to 731 12 to 727       716/907
(78 %)
26 diff
(97.2 %id)
CB161496 Liver .a 23 to 597 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
CR591514 T cells (Jurkat cell line) .a 24 to 1167 1 to 1144 exact     1144/1144
(100 %)
0 diff
(100 %id)
BX447823 T cells (Jurkat cell line) .a 24 to 632 1 to 608   fully sequenced,   608/608
(100 %)
9 diff
(98.6 %id)
CN481851 eye .a 24 to 647 1 to 624       624/624
(100 %)
0 diff
(100 %id)
BF527556 anaplastic oligodendroglioma with 1p/19qloss, brain .a 24 to 799 1 to 778       778/972
(80 %)
30 diff
(97.0 %id)
BF529084 anaplastic oligodendroglioma with 1p/19qloss, brain .a 24 to 596 1 to 571       571/571
(100 %)
3 diff
(99.5 %id)
BG107238 lymph, lymphoma, cell line .a 24 to 747 1 to 724       724/785
(92 %)
7 diff
(99.2 %id)
CF454390 peripheral nervous system .a 24 to 799 1 to 774       774/774
(100 %)
6 diff
(99.3 %id)
TI_57151469   .a 24 to 904 38 to 916       879/916
(95 %)
22 diff
(97.6 %id)
CB121346 Liver .a 24 to 477 1 to 454       454/454
(100 %)
1 diff
(99.8 %id)
TI_154173181   .a 24 to 505 80 to 566       487/687
(70 %)
18 diff
(97.4 %id)
BQ049450 lymph, lymphoma, cell line .a 25 to 855 1 to 835       835/835
(100 %)
10 diff
(98.9 %id)
BQ889500 dorsal root ganglia .a 25 to 863 1 to 843       842/931
(90 %)
12 diff
(98.8 %id)
CA489636   .a 25 to 909 1 to 887       887/887
(100 %)
8 diff
(99.1 %id)
CD300725 White Matter .a 25 to 772 1 to 757       757/887
(85 %)
17 diff
(98.1 %id)
BM912020 amelanotic melanoma, cell line, skin .a 26 to 640 1 to 623       623/1356
(45 %)
9 diff
(99.4 %id)
CA455131   .a 27 to 912 1 to 895       895/896
(99 %)
10 diff
(98.9 %id)
BM747967 Ascites, stomach .a 29 to 551 8 to 530       523/523
(100 %)
0 diff
(100 %id)
BM743900 Ascites, stomach .a 29 to 453 8 to 434       427/427
(100 %)
3 diff
(99.3 %id)
BM757004 Ascites, stomach .a 29 to 456 8 to 435       428/428
(100 %)
0 diff
(100 %id)
BM765386 Ascites, stomach .a 29 to 611 8 to 590       583/583
(100 %)
3 diff
(99.5 %id)
BM767342 Ascites, stomach .a 29 to 664 8 to 643       636/636
(100 %)
1 diff
(99.9 %id)
BE270210 Burkitt lymphoma, lymph .a 31 to 619 1 to 590       590/590
(100 %)
1 diff
(99.9 %id)
BE267706 Burkitt lymphoma, lymph .a 32 to 585 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BE254556 eye, retinoblastoma .a 32 to 698 1 to 663       663/737
(89 %)
16 diff
(97.9 %id)
CX785719 human embryonic stem cells .a 32 to 866 1 to 835       835/835
(100 %)
1 diff
(99.9 %id)
BE559496 Burkitt lymphoma, lymph .a 33 to 786 1 to 762       762/870
(87 %)
18 diff
(98.0 %id)
BM694410 eye, RPE and Choroid .a 33 to 412 1 to 381       381/389
(97 %)
3 diff
(99.3 %id)
BY799912 eye .a 34 to 595 1 to 562       562/562
(100 %)
0 diff
(100 %id)
BQ954685 large cell carcinoma, lung .a 34 to 918 1 to 894       894/927
(96 %)
21 diff
(97.8 %id)
T31047 brain .a 34 to 352 1 to 320       320/320
(100 %)
2 diff
(99.4 %id)
BE613610 leiomyosarcoma, uterus .a 35 to 459 1 to 424       424/424
(100 %)
1 diff
(99.8 %id)
BE742710 adenocarcinoma cell line, ovary .a 36 to 772 1 to 739       739/1063
(69 %)
12 diff
(98.9 %id)
AL134984 melanoma (MeWo cell line) .a 37 to 687 1 to 650       650/650
(100 %)
1 diff
(99.9 %id)
BE743950 adenocarcinoma cell line, ovary .a 37 to 870 1 to 839       839/916
(91 %)
24 diff
(97.4 %id)
BG756664 B-cells, primary B-cells from tonsils (cell line) .a 37 to 900 1 to 861       861/861
(100 %)
7 diff
(99.2 %id)
CR600563 Placenta Cot 25-normalized .a 38 to 1218 1 to 1181 exact     1181/1181
(100 %)
0 diff
(100 %id)
CR604647 Placenta Cot 25-normalized .a 38 to 1205 1 to 1168 exact     1168/1168
(100 %)
0 diff
(100 %id)
CR621665 Placenta Cot 25-normalized .a 38 to 1207 1 to 1170 exact     1170/1170
(100 %)
0 diff
(100 %id)
AL545045 placenta, Placenta Cot 25-normalized .a 38 to 632 1 to 596   fully sequenced,   596/596
(100 %)
2 diff
(99.7 %id)
AL548094 placenta, Placenta Cot 25-normalized .a 38 to 443 1 to 406   fully sequenced,   406/406
(100 %)
0 diff
(100 %id)
AL551147 placenta, Placenta Cot 25-normalized .a 38 to 632 1 to 595   fully sequenced,   595/595
(100 %)
0 diff
(100 %id)
AW406832 lymph .a 38 to 470 1 to 433       433/433
(100 %)
5 diff
(98.9 %id)
BM923006 leukocyte .a 38 to 1050 20 to 1043       1026/1061
(96 %)
41 diff
(96.2 %id)
CR601849 Placenta Cot 25-normalized .a 39 to 1207 1 to 1169 exact     1169/1169
(100 %)
0 diff
(100 %id)
AL550913 placenta, Placenta Cot 25-normalized .a 39 to 443 1 to 405   fully sequenced,   405/405
(100 %)
0 diff
(100 %id)
BE735902 adenocarcinoma, Pancreas .a 41 to 860 1 to 812       812/814
(99 %)
26 diff
(96.9 %id)
BE265795 lung, small cell carcinoma .a 42 to 599 1 to 558       558/558
(100 %)
2 diff
(99.7 %id)
BE378867 endometrium, adenocarcinoma cell line, uterus .a 42 to 818 1 to 779       777/779
(99 %)
7 diff
(99.2 %id)
BE886805 leiomyosarcoma, uterus .a 44 to 721 1 to 675       675/675
(100 %)
3 diff
(99.6 %id)
TI_154144504   .a 45 to 636 80 to 671       592/592
(100 %)
13 diff
(97.9 %id)
TI_151796941   .a 46 to 534 125 to 617       493/892
(55 %)
16 diff
(98.3 %id)
BE905938 epithelioid carcinoma, Pancreas .a 51 to 748 1 to 703       703/810
(86 %)
36 diff
(95.6 %id)
BE272271 adenocarcinoma cell line, ovary .a 54 to 650 1 to 597       597/597
(100 %)
0 diff
(100 %id)
BE549200 cervical carcinoma cell line, cervix .a 54 to 750 1 to 732   available from MGC,   730/892
(81 %)
55 diff
(93.9 %id)
EB388307 eye, optic nerve .a 58 to 499 1 to 442       442/442
(100 %)
4 diff
(99.1 %id)
CD675201 eye, lens .a 79 to 646 1 to 568       568/568
(100 %)
6 diff
(99.0 %id)
CR620315 T cells (Jurkat cell line) Cot10-normalized .a 84 to 1229 1 to 1146 exact     1146/1146
(100 %)
0 diff
(100 %id)
TI_45211859   .a 93 to 918 78 to 909       832/996
(83 %)
25 diff
(97.5 %id)
TI_44346217   .a 93 to 1071 118 to 1093       976/1095
(89 %)
43 diff
(96.1 %id)
CR623440 Neuroblastoma Cot 10-normalized .a 96 to 1197 1 to 1102 exact     1102/1102
(100 %)
0 diff
(100 %id)
BI600379 brain, hypothalamus .a 96 to 918 1 to 828       828/915
(90 %)
22 diff
(97.6 %id)
BI668251 brain, hypothalamus .a 97 to 1071 1 to 972       972/974
(99 %)
39 diff
(96.0 %id)
TI_1241112337   .a 98 to 1009 924 to 14       911/1251
(72 %)
3 diff
(99.8 %id)
TI_1241112345   .a 98 to 748 652 to 2       651/1243
(52 %)
2 diff
(99.9 %id)
TI_1241112873   .a 98 to 786 51 to 742       692/803
(86 %)
59 diff
(92.7 %id)
TI_1241111045   .a 98 to 1145 44 to 1088 Q228K Q307R K316T D317T E318K ...     1045/1247
(83 %)
13 diff
(99.0 %id)
TI_1241112339   .a 98 to 1007 922 to 14       909/1233
(73 %)
3 diff
(99.8 %id)
TI_1241112347   .a 98 to 748 654 to 4       651/1238
(52 %)
2 diff
(99.9 %id)
TI_1241112903   .a 98 to 1145 42 to 1081 Q228K Q307R I313S R314A Q315E ...     1040/1248
(83 %)
18 diff
(98.6 %id)
TI_1241113287   .a 98 to 1156 1120 to 64 R16P V17C I18D Q19T E20G ...     1057/1271
(83 %)
10 diff
(99.3 %id)
BC104797 Brain, cerebral cortex, PCR rescued clones .a 102 to 1150 1 to 1049 Q228K Q307R     1049/1049
(100 %)
2 diff
(99.9 %id)
BC104827 Brain, cerebral cortex, PCR rescued clones .a 102 to 1150 1 to 1049 Q228K Q307R     1049/1049
(100 %)
2 diff
(99.9 %id)
BM756022 Ascites, stomach .a 104 to 653 1 to 550       550/550
(100 %)
0 diff
(100 %id)
TI_1241113257   .a 109 to 1150 1104 to 69 A2D D3I I5A A6*     1036/1213
(85 %)
15 diff
(98.8 %id)
BI763490 pooled colon, kidney, stomach .a 109 to 947 1 to 842       842/853
(98 %)
10 diff
(98.9 %id)
TI_57152136   .a 109 to 1025 96 to 1014       919/1014
(90 %)
23 diff
(97.8 %id)
DB467939 hippocampus .a 110 to 568 1 to 459       459/462
(99 %)
3 diff
(99.4 %id)
BG390424 embryonal carcinoma, cell line, testis .a 110 to 648 1 to 539       539/539
(100 %)
0 diff
(100 %id)
BI769295 pooled lung and spleen .a 110 to 977 1 to 869       869/869
(100 %)
12 diff
(98.7 %id)
TI_57179063   .a 110 to 977 32 to 900       869/900
(96 %)
16 diff
(98.3 %id)
CB106444 Liver .a 110 to 546 1 to 437       437/437
(100 %)
1 diff
(99.8 %id)
CB107930 Liver .a 110 to 596 1 to 487       487/487
(100 %)
2 diff
(99.6 %id)
CB119764 Liver .a 110 to 546 1 to 437       437/437
(100 %)
0 diff
(100 %id)
DB491374 hypothalamus .a 111 to 534 1 to 423       423/426
(99 %)
6 diff
(98.6 %id)
BG036053 adenocarcinoma, cell line, Liver .a 112 to 796 1 to 691       691/715
(96 %)
13 diff
(98.2 %id)
BX406054 fetal liver, Liver .a 113 to 1150 1 to 1021 I18K G21E R22P G23R E24R ...     1021/1048
(97 %)
55 diff
(94.8 %id)
AL521013 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 114 to 632 14 to 532   fully sequenced,   519/532
(97 %)
7 diff
(98.7 %id)
DN989852 brain, whole brain .a 114 to 683 1 to 570       570/570
(100 %)
5 diff
(99.2 %id)
TI_1241111049   .a 115 to 1156 1102 to 68 A2I D3S I4S I5Q A6T ...     1033/1231
(83 %)
11 diff
(99.2 %id)
AI940343 colon .a 117 to 428 1 to 311       311/311
(100 %)
6 diff
(98.1 %id)
AI940385 colon .a 117 to 428 1 to 311       311/311
(100 %)
6 diff
(98.1 %id)
AW806496 stomach .a 117 to 263 7 to 152       146/152
(96 %)
5 diff
(96.8 %id)
AW806522 stomach .a 117 to 676 12 to 568       557/568
(98 %)
14 diff
(97.6 %id)
AW806524 stomach .a 117 to 584 26 to 491       466/491
(94 %)
10 diff
(98.0 %id)
AW806527 stomach .a 117 to 661 10 to 554       545/554
(98 %)
7 diff
(98.8 %id)
BE140224 head_neck .a 117 to 263 7 to 152       146/152
(96 %)
5 diff
(96.8 %id)
BP431025   .a 117 to 511 1 to 398       398/398
(100 %)
8 diff
(98.0 %id)
BM012082 brain, neuroblastoma, cell line .a 118 to 969 1 to 854       854/854
(100 %)
10 diff
(98.9 %id)
TI_59381279   .a 118 to 969 99 to 952       854/854
(100 %)
10 diff
(98.9 %id)
AW062401 colon .a 119 to 249 12 to 137       126/137
(91 %)
6 diff
(95.7 %id)
BG576009 breast, mammary adenocarcinoma, cell line .a 119 to 619 1 to 501       501/501
(100 %)
0 diff
(100 %id)
BQ108633 brain, neuroblastoma, cell line .a 119 to 858 1 to 739       739/739
(100 %)
6 diff
(99.2 %id)
CN399891 embryonic stem cells, cell lines H1, H7, andH9 .a 120 to 779 1 to 660       660/662
(99 %)
4 diff
(99.4 %id)
BI261637 lymph, lymphoma, cell line .a 120 to 1019 1 to 899       899/912
(98 %)
22 diff
(97.6 %id)
BI261748 lymph, lymphoma, cell line .a 120 to 809 1 to 688   fully sequenced,   688/688
(100 %)
1 diff
(99.9 %id)
BU190162 leiomyosarcoma, uterus .a 120 to 949 1 to 837       837/837
(100 %)
12 diff
(98.6 %id)
BP430226   .a 120 to 553 1 to 434       434/434
(100 %)
1 diff
(99.8 %id)
AW806554 stomach .a 121 to 689 15 to 582       568/582
(97 %)
29 diff
(95.1 %id)
AL558699 T cells from T cell leukemia .a 121 to 1111 1 to 983       983/983
(100 %)
17 diff
(98.3 %id)
BX402805   .a 121 to 1169 1065 to 18 D3X R7K D11N E20K E24X ...     1048/1070
(97 %)
20 diff
(98.2 %id)
BX402806   .a 121 to 1229 30 to 1136 Q228K Q307R R325P I327D F328L ...     1107/1136
(97 %)
20 diff
(98.3 %id)
BQ637349 eye, retina .a 121 to 719 1 to 599       599/599
(100 %)
0 diff
(100 %id)
W39176 parathyroid gland, parathyroid tumor .a 121 to 553 15 to 458       444/459
(96 %)
19 diff
(95.9 %id)
BE799833 lung, small cell carcinoma .a 121 to 943 11 to 830       820/841
(97 %)
22 diff
(97.4 %id)
BI820432 pooled brain, lung, testis .a 121 to 891 1 to 771       771/771
(100 %)
1 diff
(99.9 %id)
BM920918 pooled brain, lung, testis .a 121 to 1131 19 to 1040 Q228K N259K K260Q N264X K270Q ...     1022/1043
(97 %)
33 diff
(96.9 %id)
TI_57197741   .a 121 to 891 36 to 806       771/806
(95 %)
7 diff
(99.2 %id)
AW845086 colon .a 122 to 761 1 to 639       639/639
(100 %)
13 diff
(98.0 %id)
CN399895 embryonic stem cells, cell lines H1, H7, andH9 .a 122 to 797 1 to 676       676/676
(100 %)
2 diff
(99.8 %id)
CR600666 Neuroblastoma Cot 25-normalized .a 122 to 1144 1 to 1023 exact     1023/1023
(100 %)
0 diff
(100 %id)
CR601190 B cells (Ramos cell line) Cot 25-normalized .a 122 to 1233 1 to 1112 exact     1112/1112
(100 %)
0 diff
(100 %id)
AL525905 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 122 to 632 1 to 511   fully sequenced,   511/511
(100 %)
0 diff
(100 %id)
AL561031 B cells from Burkitt lymphoma .a 122 to 1214 1 to 1081 L50A D51G D52R S53Q R54P ... fully sequenced,   1081/1081
(100 %)
22 diff
(98.0 %id)
BG420423 Kidney, renal cell adenocarcinoma .a 122 to 916 1 to 792       792/882
(89 %)
31 diff
(96.5 %id)
BI906432 leukocyte .a 122 to 861 1 to 743       743/743
(100 %)
8 diff
(99.0 %id)
BQ944609 carcinoma, cell line, Prostate .a 122 to 883 1 to 765       765/942
(81 %)
8 diff
(99.2 %id)
TI_57232356   .a 122 to 861 27 to 769       743/769
(96 %)
14 diff
(98.2 %id)
BM698875 eye, fetal eyes .a 122 to 675 1 to 554       554/554
(100 %)
2 diff
(99.7 %id)
BQ896298 brain, neuroblastoma, cell line .a 123 to 1032 22 to 937       916/940
(97 %)
33 diff
(96.5 %id)
CD579232 brain .a 123 to 920 1 to 791       791/981
(80 %)
18 diff
(98.2 %id)
AI909796 breast .a 124 to 412 1 to 288       288/366
(78 %)
9 diff
(97.6 %id)
AW176528 colon .a 124 to 249 124 to 1       126/124
(101 %)
6 diff
(95.2 %id)
AW806473 stomach .a 124 to 572 1 to 448       448/448
(100 %)
4 diff
(99.2 %id)
AW806486 stomach .a 124 to 238 1 to 113       113/135
(83 %)
5 diff
(96.3 %id)
AW806515 stomach .a 124 to 534 409 to 1       409/409
(100 %)
3 diff
(99.3 %id)
AW806531 stomach .a 124 to 437 316 to 4       313/316
(99 %)
0 diff
(100 %id)
AW844926 colon .a 124 to 291 1 to 168       168/168
(100 %)
2 diff
(98.9 %id)
AW845003 colon .a 124 to 653 1 to 530       530/530
(100 %)
5 diff
(99.1 %id)
AW845028 colon .a 124 to 719 1 to 596       596/596
(100 %)
1 diff
(99.9 %id)
AW938779 denis_drash .a 124 to 579 1 to 456       456/456
(100 %)
3 diff
(99.4 %id)
BE140187 head_neck .a 124 to 570 1 to 447       447/447
(100 %)
1 diff
(99.8 %id)
BE140208 head_neck .a 124 to 719 1 to 596       596/596
(100 %)
1 diff
(99.9 %id)
BE140209 head_neck .a 124 to 627 1 to 504       504/504
(100 %)
9 diff
(98.3 %id)
BE140235 head_neck .a 124 to 543 420 to 1     Submitted on the opposite strand 420/420
(100 %)
1 diff
(99.8 %id)
BE140271 head_neck .a 124 to 693 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
BE140287 head_neck .a 124 to 573 1 to 450       450/450
(100 %)
2 diff
(99.6 %id)
BE140408 head_neck .a 124 to 291 1 to 168       168/168
(100 %)
2 diff
(98.9 %id)
BF374294 stomach .a 124 to 265 1 to 142       142/144
(98 %)
1 diff
(99.4 %id)
CR593870 Placenta Cot 25-normalized .a 124 to 1132 1 to 1009 exact     1009/1009
(100 %)
0 diff
(100 %id)
CR604495 B cells (Ramos cell line) Cot 25-normalized .a 124 to 1204 1 to 1081 exact     1081/1081
(100 %)
0 diff
(100 %id)
AL554368 placenta, Placenta Cot 25-normalized .a 124 to 1009 1 to 887       887/887
(100 %)
10 diff
(98.9 %id)
AL582989 B cells from Burkitt lymphoma .a 124 to 1166 1 to 1040 L50A D51G D52R S53Q R54P ...     1040/1067
(97 %)
26 diff
(97.6 %id)
BX386810   .a 124 to 1095 1 to 967       967/1045
(92 %)
15 diff
(98.6 %id)
BG476049 melanotic melanoma, skin .a 124 to 561 1 to 440       440/999
(44 %)
3 diff
(99.7 %id)
BG477719 melanotic melanoma, skin .a 124 to 1043 1 to 916       916/974
(94 %)
29 diff
(97.1 %id)
U31913 lymphoma .a 125 to 1236 1 to 1112 Q307R     1112/1120
(99 %)
4 diff
(99.7 %id)
BE409728 choriocarcinoma, placenta .a 126 to 778 1 to 654       654/718
(91 %)
9 diff
(98.8 %id)
BU846005 ovary, teratocarcinoma, cell line .a 126 to 1025 1 to 914       914/914
(100 %)
20 diff
(97.9 %id)
AV747441 Pituitary .a 126 to 259 1 to 131       131/131
(100 %)
4 diff
(97.0 %id)
BU949754 Pancreas, Purified pancreatic islet .a 127 to 742 1 to 616     Submitted on the opposite strand 616/616
(100 %)
7 diff
(98.9 %id)
BX386809   .a 128 to 1204 1059 to 1 A2R D3F I4H I5R A6X ...     1059/1061
(99 %)
60 diff
(94.4 %id)
BM556637 duodenal adenocarcinoma, cell line, small intestine .a 128 to 720 1 to 601       601/986
(60 %)
9 diff
(99.1 %id)
BE869978 adenocarcinoma, colon .a 129 to 513 1 to 401       357/403
(88 %)
10 diff
(97.6 %id)
BI859906 breast, mammary adenocarcinoma, cell line .a 129 to 986 1 to 857       857/858
(99 %)
12 diff
(98.7 %id)
TI_57188808   .a 129 to 986 56 to 912       857/858
(99 %)
12 diff
(98.7 %id)
T32201 skin .a 129 to 396 1 to 269       269/269
(100 %)
5 diff
(98.2 %id)
BQ229371 large cell carcinoma, lung .a 130 to 794 1 to 665       665/929
(71 %)
18 diff
(98.1 %id)
BQ687029 ductal carcinoma, cell line, Pancreas .a 130 to 972 1 to 847       847/849
(99 %)
16 diff
(98.2 %id)
AI909774 breast .a 131 to 555 1 to 432       432/435
(99 %)
12 diff
(97.3 %id)
BQ062331 lymph, lymphoma, cell line .a 133 to 1111 1 to 993       993/1022
(97 %)
45 diff
(95.6 %id)
BE891627 melanotic melanoma, skin .a 135 to 712 1 to 578       578/579
(99 %)
1 diff
(99.9 %id)
BU558013 adenocarcinoma, cell line, breast .a 135 to 1062 1 to 928       928/928
(100 %)
22 diff
(97.7 %id)
AW957850   .a 136 to 772 1 to 635       635/646
(98 %)
16 diff
(97.6 %id)
ES307700 beard hair, skin .a 136 to 350 1 to 215       215/215
(100 %)
0 diff
(100 %id)
BE909973 epithelioid carcinoma, Pancreas .a 136 to 865 1 to 728       728/729
(99 %)
7 diff
(99.1 %id)
BM542814 leiomyosarcoma, uterus .a 136 to 915 41 to 825       785/1199
(65 %)
27 diff
(97.8 %id)
AI909775 breast .a 137 to 579 1 to 450       450/451
(99 %)
20 diff
(95.6 %id)
BM708827 eye, RPE and Choroid .a 137 to 649 1 to 513   fully sequenced,   513/513
(100 %)
1 diff
(99.9 %id)
AA307009 colon .a 138 to 388 1 to 251       251/251
(100 %)
1 diff
(99.7 %id)
AA321879 brain, cerebellum .a 138 to 373 1 to 237       237/237
(100 %)
2 diff
(99.2 %id)
CR601003 T cells (Jurkat cell line) Cot10-normalized .a 138 to 1218 1 to 1081       1081/1081
(100 %)
0 diff
(100 %id)
AL558532 T cells from T cell leukemia .a 138 to 1156 1 to 1014   fully sequenced,   1014/1014
(100 %)
17 diff
(98.4 %id)
CF455858 peripheral nervous system .a 138 to 888 41 to 790       750/790
(94 %)
13 diff
(98.4 %id)
CB269813 adipose .a 139 to 494 1 to 356       356/358
(99 %)
2 diff
(99.5 %id)
BE791743 lung, small cell carcinoma .a 140 to 918 1 to 786       786/1037
(75 %)
16 diff
(98.5 %id)
BE791789 lung, small cell carcinoma .a 140 to 916 1 to 791       789/870
(90 %)
20 diff
(97.8 %id)
BE795399 lung, small cell carcinoma .a 140 to 917 1 to 773       773/774
(99 %)
9 diff
(98.9 %id)
BQ709140 Spleen .a 140 to 1025 1 to 896       896/929
(96 %)
18 diff
(98.1 %id)
BF034161 adenocarcinoma, ovary .a 141 to 789 1 to 653       653/822
(79 %)
10 diff
(98.8 %id)
BF037231 adenocarcinoma, ovary .a 141 to 791 1 to 647       647/647
(100 %)
8 diff
(98.8 %id)
BU785030 Pancreas, Purified pancreatic islet .a 142 to 579 1 to 438     Submitted on the opposite strand 438/438
(100 %)
0 diff
(100 %id)
BE780998 eye, retinoblastoma .a 143 to 904 1 to 764       764/764
(100 %)
13 diff
(98.3 %id)
AI940340 colon .a 144 to 646 1 to 509       507/509
(99 %)
19 diff
(96.3 %id)
AI940381 colon .a 144 to 646 1 to 509       507/509
(99 %)
19 diff
(96.3 %id)
BG111667 Bone, osteosarcoma, cell line .a 144 to 919 1 to 778       776/1077
(72 %)
15 diff
(98.7 %id)
BF337387 brain, glioblastoma with EGFR amplification .a 146 to 908 1 to 763       763/763
(100 %)
10 diff
(98.7 %id)
BG768764 melanotic melanoma, high MDR (cell line), skin .a 146 to 1011 1 to 870       870/870
(100 %)
13 diff
(98.6 %id)
BF127945 leiomyosarcoma cell line, uterus .a 147 to 779 1 to 626       626/895
(69 %)
16 diff
(98.3 %id)
BQ694050 adipose .a 149 to 683 1 to 535       535/535
(100 %)
0 diff
(100 %id)
BE745947 adenocarcinoma cell line, ovary .a 151 to 1029 1 to 871       871/977
(89 %)
21 diff
(97.9 %id)
BE538058 cervix .a 153 to 768 1 to 627       627/646
(97 %)
24 diff
(96.3 %id)
TI_57164572   .a 155 to 802 15 to 661       647/661
(97 %)
6 diff
(99.1 %id)
AW406332 lymph .a 158 to 633 1 to 475       475/475
(100 %)
4 diff
(99.2 %id)
BG115995 duodenal adenocarcinoma, cell line, small intestine .a 158 to 892 1 to 750       748/1143
(65 %)
43 diff
(96.3 %id)
TI_154143906   .a 166 to 705 69 to 608       540/540
(100 %)
5 diff
(99.1 %id)
CB266724 adipose .a 171 to 595 1 to 426       426/426
(100 %)
4 diff
(99.1 %id)
BI834098 pooled pancreas and spleen .a 173 to 802 1 to 630       630/630
(100 %)
0 diff
(100 %id)
CR975578 T-Lymphocytes .a 174 to 749 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
CR989622 T-Lymphocytes .a 174 to 865 1 to 692       692/692
(100 %)
1 diff
(99.9 %id)
CT004586 T-Lymphocytes .a 174 to 971 1 to 798       798/798
(100 %)
1 diff
(99.9 %id)
CR989608 T-Lymphocytes .a 174 to 1043 1 to 871       871/876
(99 %)
4 diff
(99.6 %id)
CR987375 T-Lymphocytes .a 174 to 874 1 to 702       702/702
(100 %)
2 diff
(99.8 %id)
CR989525 T-Lymphocytes .a 174 to 993 1 to 820       820/821
(99 %)
6 diff
(99.3 %id)
CR985661 T-Lymphocytes .a 174 to 839 1 to 668       668/671
(99 %)
4 diff
(99.5 %id)
CR983384 T-Lymphocytes .a 174 to 1018 1 to 847       847/847
(100 %)
3 diff
(99.7 %id)
CR992359 T-Lymphocytes .a 174 to 861 1 to 688       688/688
(100 %)
2 diff
(99.8 %id)
CR999883 T-Lymphocytes .a 174 to 1018 1 to 842       842/842
(100 %)
10 diff
(98.9 %id)
CT002365 T-Lymphocytes .a 174 to 672 1 to 499       499/500
(99 %)
3 diff
(99.4 %id)
CR989408 T-Lymphocytes .a 174 to 864 1 to 691       691/691
(100 %)
1 diff
(99.9 %id)
CR980517 T-Lymphocytes .a 174 to 858 1 to 685       685/685
(100 %)
1 diff
(99.9 %id)
BF975140 B-cells, primary B-cells from tonsils (cell line) .a 176 to 918 1 to 741       741/950
(78 %)
13 diff
(98.7 %id)
BQ225003 leiomyosarcoma, uterus .a 176 to 1184 1 to 1011       1011/1011
(100 %)
42 diff
(95.9 %id)
BU790551 Pancreas, Purified pancreatic islet .a 179 to 660 1 to 483   fully sequenced,   483/483
(100 %)
4 diff
(99.2 %id)
BU168722 ductal carcinoma, cell line, Pancreas .a 192 to 986 1 to 798       798/847
(94 %)
10 diff
(98.9 %id)
BG681916 skin, squamous cell carcinoma .a 203 to 925 1 to 725       725/846
(85 %)
10 diff
(98.9 %id)
BM016514 breast, mammary adenocarcinoma, cell line .a 203 to 976 1 to 774       774/774
(100 %)
1 diff
(99.9 %id)
TI_59394136   .a 203 to 976 90 to 863       774/774
(100 %)
1 diff
(99.9 %id)
AL582937 B cells from Burkitt lymphoma .a 224 to 1160 957 to 23       935/1037
(90 %)
7 diff
(99.4 %id)
AW751338 colon .a 230 to 813 596 to 16       581/669
(86 %)
13 diff
(98.1 %id)
AL580465 T cells from T cell leukemia .a 231 to 1204 970 to 1       970/977
(99 %)
27 diff
(97.3 %id)
BG911267 anaplastic oligodendroglioma with 1p/19qloss, brain .a 233 to 985 1 to 749       749/749
(100 %)
7 diff
(99.1 %id)
BU176248 epithelioid carcinoma, Pancreas .a 235 to 1102 1 to 874       874/877
(99 %)
15 diff
(98.3 %id)
AW806510 stomach .a 256 to 835 591 to 12       580/591
(98 %)
3 diff
(99.5 %id)
AW806666 stomach .a 257 to 827 571 to 1       571/571
(100 %)
4 diff
(99.3 %id)
CA396684 eye, RPE/choroid .a 266 to 785 1 to 520       520/520
(100 %)
0 diff
(100 %id)
AW806656 stomach .a 269 to 825 559 to 3       557/559
(99 %)
0 diff
(100 %id)
BM710808 eye, fetal eyes .a 273 to 584 1 to 312       312/312
(100 %)
0 diff
(100 %id)
BQ900324 carcinoma, cell line, Prostate .a 278 to 1111 1 to 839       839/909
(92 %)
19 diff
(98.0 %id)
TI_154193554   .a 280 to 1150 50 to 915       866/1011
(85 %)
17 diff
(98.4 %id)
CF127867 Chondrosarcoma Lung Metastasis cell lines, lung .a 281 to 1052 1 to 771       771/771
(100 %)
4 diff
(99.5 %id)
CR594744 B cells (Ramos cell line) Cot 25-normalized .a 282 to 1232 1 to 951       951/951
(100 %)
0 diff
(100 %id)
AL561202 B cells from Burkitt lymphoma .a 282 to 1232 1 to 951   fully sequenced,   951/951
(100 %)
5 diff
(99.5 %id)
EL955351 eyeball .a 298 to 814 23 to 527       505/529
(95 %)
17 diff
(96.8 %id)
BE614332 leiomyosarcoma, uterus .a 298 to 936 647 to 1       645/719
(89 %)
32 diff
(95.6 %id)
AW806529 stomach .a 307 to 835 532 to 3       530/532
(99 %)
13 diff
(97.6 %id)
BI829797 brain, medulla .a 314 to 958 1 to 645       645/645
(100 %)
2 diff
(99.7 %id)
TI_57176363   .a 314 to 1183 30 to 900       871/902
(96 %)
14 diff
(98.5 %id)
AA455316 germinal center B cell .a 315 to 796 1 to 479   fully sequenced,   479/479
(100 %)
5 diff
(99.0 %id)
BM045724 carcinoma, cell line, Prostate .a 327 to 1201 1 to 875       875/875
(100 %)
9 diff
(99.0 %id)
BM045747 carcinoma, cell line, Prostate .a 327 to 1057 1 to 759       709/759
(93 %)
43 diff
(94.4 %id)
AI214088 astrocytoma, brain .a 329 to 711 1 to 383     Submitted on the opposite strand 383/384
(99 %)
8 diff
(98.0 %id)
AW161315 brain, frontal lobe .a 329 to 604 1 to 276       276/276
(100 %)
2 diff
(99.3 %id)
TI_1971554935   .a 331 to 1172 251 to 1088     Submitted on the opposite strand 838/1269
(66 %)
37 diff
(97.1 %id)
TI_1971555051   .a 331 to 1178 250 to 1093     Submitted on the opposite strand 844/1280
(65 %)
27 diff
(97.9 %id)
AW806667 stomach .a 339 to 778 490 to 33       475/490
(96 %)
79 diff
(83.9 %id)
BG330142 large cell carcinoma, lung .a 344 to 1167 1 to 823       823/834
(98 %)
20 diff
(97.7 %id)
AW806528 stomach .a 348 to 827 483 to 1       483/487
(99 %)
7 diff
(98.6 %id)
TI_159681477   .a 364 to 1234 947 to 85   AAA   863/1022
(84 %)
23 diff
(97.8 %id)
TI_149313614   .a 381 to 1236 934 to 85   AAA   850/944
(90 %)
10 diff
(99.0 %id)
AL572783 placenta, Placenta Cot 25-normalized .a 382 to 1208 832 to 10   fully sequenced,   823/832
(98 %)
1 diff
(99.9 %id)
AL574481 placenta, Placenta Cot 25-normalized .a 382 to 1132 793 to 42   fully sequenced,   752/793
(94 %)
4 diff
(99.5 %id)
AL574642 placenta, Placenta Cot 25-normalized .a 382 to 1207 823 to 1   fully sequenced,   823/823
(100 %)
8 diff
(99.1 %id)
AW845041 colon .a 398 to 827 430 to 1       430/430
(100 %)
1 diff
(99.8 %id)
BU146409 epidermoid carcinoma, cell line, salivary gland .a 411 to 1236 1 to 826   AAA   826/826
(100 %)
6 diff
(99.3 %id)
AI909778 breast .a 414 to 818 411 to 4       408/493
(82 %)
8 diff
(98.4 %id)
BQ417256 Pancreas, Purified pancreatic islet .a 415 to 1052 1 to 638       638/640
(99 %)
7 diff
(99.0 %id)
BM552615 astrocytoma grade IV, cell line, brain .a 421 to 1236 873 to 47   AAA Submitted on the opposite strand 827/986
(83 %)
17 diff
(98.3 %id)
TI_149311177   .a 428 to 1236 888 to 84   AAA   805/975
(82 %)
10 diff
(99.0 %id)
TI_149314021   .a 428 to 1234 892 to 92   AAA   801/953
(84 %)
11 diff
(98.9 %id)
TI_154127969   .a 428 to 1235 905 to 103   AAA   803/965
(83 %)
13 diff
(98.7 %id)
AI907841 breast .a 433 to 1021 1 to 586       586/591
(99 %)
26 diff
(95.7 %id)
CK825928 Pancreas, Purified pancreatic islet .a 462 to 1038 1 to 577     Submitted on the opposite strand 577/577
(100 %)
1 diff
(99.9 %id)
AI920942 adenocarcinoma, Pancreas .a 463 to 1240 774 to 1       775/774
(100 %)
17 diff
(97.9 %id)
BF530299 anaplastic oligodendroglioma with 1p/19qloss, brain .a 463 to 956 1 to 494       494/494
(100 %)
1 diff
(99.8 %id)
AI798872 pooled .a 472 to 1235 757 to 1       758/757
(100 %)
22 diff
(97.1 %id)
BQ774651 Bone, Human Chondrosarcoma Cell Line .a 497 to 1236 756 to 19   AAA   738/738
(100 %)
4 diff
(99.5 %id)
BQ421312 epithelioid carcinoma, Pancreas .a 503 to 1236 758 to 18   AAA Submitted on the opposite strand 741/880
(84 %)
10 diff
(98.9 %id)
BQ575087 Chondrosarcoma Grade II, Left Pelvis .a 503 to 1234 750 to 19   AAA   732/732
(100 %)
2 diff
(99.8 %id)
AW751327 colon .a 508 to 824 1 to 317       317/317
(100 %)
11 diff
(96.6 %id)
AW751333 colon .a 508 to 824 1 to 317       317/317
(100 %)
11 diff
(96.6 %id)
EC570351 Prostate .a 513 to 604 1 to 95       95/96
(98 %)
4 diff
(95.9 %id)
CR618527 placenta .a 527 to 1234 1 to 708       708/708
(100 %)
0 diff
(100 %id)
TI_57233283   .a 527 to 1214 59 to 747       689/747
(92 %)
8 diff
(99.0 %id)
BX439464 placenta .a 534 to 1234 10 to 710       701/710
(98 %)
9 diff
(98.8 %id)
CB305487 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 534 to 1236 721 to 19   AAA   703/703
(100 %)
2 diff
(99.8 %id)
BQ774661 Bone, Human Chondrosarcoma Cell Line .a 534 to 1236 721 to 19   AAA   703/703
(100 %)
2 diff
(99.8 %id)
CA307912 Alveolar Macrophage, lung .a 534 to 1236 721 to 19   AAA   703/703
(100 %)
2 diff
(99.8 %id)
BI906812 leukocyte .a 535 to 958 1 to 424       424/424
(100 %)
2 diff
(99.6 %id)
AA460855   .a 539 to 809 1 to 269   fully sequenced,   269/269
(100 %)
2 diff
(99.3 %id)
TI_149294087   .a 541 to 1236 769 to 78   AAA   692/693
(99 %)
10 diff
(98.6 %id)
AW845009 colon .a 542 to 835 310 to 17       294/310
(94 %)
1 diff
(99.7 %id)
BU689235 lung .a 545 to 1236 711 to 19   AAA   693/693
(100 %)
2 diff
(99.8 %id)
BU631249 cell lines, Chondrosarcoma .a 549 to 1236 706 to 19   AAA   688/688
(100 %)
3 diff
(99.6 %id)
BE938385 testis_normal .a 551 to 912 362 to 2       361/391
(92 %)
0 diff
(100 %id)
BQ003417 Chondrosarcoma, Left Pelvis .a 555 to 1232 698 to 19   AAA   680/680
(100 %)
5 diff
(99.3 %id)
CB305826 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 556 to 1234 697 to 19   AAA   679/679
(100 %)
3 diff
(99.6 %id)
BU625332 cell lines, Enchondroma .a 556 to 1236 699 to 19   AAA   681/681
(100 %)
3 diff
(99.6 %id)
BU629717 cell lines, Chondrosarcoma .a 556 to 1234 698 to 19   AAA   680/680
(100 %)
3 diff
(99.6 %id)
BU630636 cell lines, Chondrosarcoma .a 556 to 1229 692 to 19   AAA   674/674
(100 %)
2 diff
(99.8 %id)
BU629828 cell lines, Chondrosarcoma .a 556 to 1236 699 to 19   AAA   681/681
(100 %)
2 diff
(99.8 %id)
BU633598 cell lines, Chondrosarcoma .a 556 to 1234 697 to 19   AAA   679/679
(100 %)
2 diff
(99.8 %id)
CD369957 Alveolar Macrophage, lung .a 556 to 1236 700 to 19   AAA   682/682
(100 %)
3 diff
(99.6 %id)
AL521012 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 571 to 1193 624 to 4   fully sequenced,   621/624
(99 %)
2 diff
(99.7 %id)
AL525863 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 571 to 1126 588 to 23   fully sequenced,   566/588
(96 %)
3 diff
(99.5 %id)
BX447822 T cells (Jurkat cell line) .a 571 to 1167 598 to 1   fully sequenced,   598/598
(100 %)
15 diff
(97.5 %id)
AL570935 placenta, Placenta Cot 25-normalized .a 571 to 1174 635 to 33   fully sequenced,   603/635
(94 %)
6 diff
(99.1 %id)
AL574795 placenta, Placenta Cot 25-normalized .a 571 to 1189 629 to 16   fully sequenced,   614/629
(97 %)
1 diff
(99.9 %id)
AL580330 T cells from T cell leukemia .a 571 to 1172 645 to 44   fully sequenced,   602/645
(93 %)
8 diff
(98.8 %id)
AL561179 B cells from Burkitt lymphoma .a 571 to 1202 633 to 1   fully sequenced,   633/633
(100 %)
9 diff
(98.6 %id)
AL582336 B cells from Burkitt lymphoma .a 571 to 1191 640 to 23   fully sequenced,   618/640
(96 %)
7 diff
(99.0 %id)
AA916765 carcinoid, lung .a 572 to 1234 670 to 7       664/675
(98 %)
7 diff
(99.0 %id)
AA385138 thyroid gland .a 575 to 873 1 to 300       300/300
(100 %)
3 diff
(99.0 %id)
BQ574529 Chondrosarcoma Grade II, Left Pelvis .a 582 to 1235 672 to 19   AAA   654/654
(100 %)
4 diff
(99.4 %id)
BQ575306 Chondrosarcoma Grade II, Left Pelvis .a 582 to 1236 673 to 19   AAA   655/655
(100 %)
2 diff
(99.7 %id)
CA314711 Human Lung Epithelial cells, lung .a 585 to 1235 670 to 19   AAA   652/652
(100 %)
3 diff
(99.6 %id)
BG029017 Bone, osteosarcoma, cell line .a 589 to 1232 1 to 638       638/704
(90 %)
10 diff
(98.6 %id)
AI953792 brain, three pooled meningiomas .a 596 to 1232 680 to 45   AAA   636/752
(84 %)
56 diff
(92.6 %id)
AW054999 brain, glioblastoma (pooled) .a 597 to 1236 641 to 1       641/672
(95 %)
16 diff
(97.7 %id)
CA307557 Alveolar Macrophage, lung .a 597 to 1236 658 to 19   AAA   640/640
(100 %)
5 diff
(99.3 %id)
CA310099 Alveolar Macrophage, lung .a 597 to 1236 659 to 19   AAA   641/641
(100 %)
5 diff
(99.3 %id)
CA310108 Alveolar Macrophage, lung .a 597 to 1234 655 to 17   AAA   639/639
(100 %)
5 diff
(99.3 %id)
BQ774314 Chondrosarcoma Grade II, Left Pelvis .a 600 to 1234 654 to 19   AAA   636/638
(99 %)
6 diff
(99.1 %id)
CD370472 Alveolar Macrophage, lung .a 600 to 1234 653 to 19   AAA   635/637
(99 %)
5 diff
(99.3 %id)
CN480874 Aveolar Macrophage, lung .a 600 to 1240 659 to 19   AAA   641/643
(99 %)
3 diff
(99.6 %id)
BX375912 Neuroblastoma Cot 25-normalized .a 601 to 1191 611 to 17       595/920
(64 %)
12 diff
(98.7 %id)
AW103440 ovary, tumor, 5 pooled (see description) .a 604 to 1236 636 to 2       635/758
(83 %)
16 diff
(97.9 %id)
BU785296 Pancreas, Purified pancreatic islet .a 607 to 1229 623 to 1     Submitted on the opposite strand 623/623
(100 %)
2 diff
(99.7 %id)
AA876185 pooled germ cell tumors .a 608 to 1181 573 to 1       573/573
(100 %)
18 diff
(96.9 %id)
BX437513 thymus .a 611 to 1175 562 to 1       562/562
(100 %)
17 diff
(97.0 %id)
BU950057 Pancreas, Purified pancreatic islet .a 614 to 1236 641 to 20   AAA Submitted on the opposite strand 622/622
(100 %)
12 diff
(98.1 %id)
BQ574171 Chondrosarcoma Grade II, Left Pelvis .a 616 to 1234 637 to 19   AAA   619/619
(100 %)
2 diff
(99.7 %id)
BU731512 eye, RPE and Choroid .a 619 to 1236 636 to 19   fully sequenced, AAA   618/618
(100 %)
2 diff
(99.7 %id)
CA424056 cell lines, Chondrosarcoma .a 619 to 1236 636 to 19   AAA   618/618
(100 %)
3 diff
(99.6 %id)
BG026294 Bone, osteosarcoma, cell line .a 625 to 1236 1 to 612   AAA   612/612
(100 %)
2 diff
(99.7 %id)
BQ231990 embryonal carcinoma, cell line, testis .a 627 to 1236 1 to 610       610/614
(99 %)
3 diff
(99.6 %id)
BU790255 Pancreas, Purified pancreatic islet .a 630 to 1236 610 to 5   fully sequenced,   606/610
(99 %)
1 diff
(99.9 %id)
BQ287799 Pancreas, Purified pancreatic islet .a 632 to 1235 604 to 1       604/604
(100 %)
2 diff
(99.7 %id)
BE466281 malignant melanoma, metastatic to lymphnode, skin .a 635 to 1236 604 to 3       602/604
(99 %)
12 diff
(98.1 %id)
AW581120 leiomios .a 638 to 846 1 to 210       210/210
(100 %)
2 diff
(99.1 %id)
AI074825 senescent fibroblast .a 638 to 1232 595 to 6       590/595
(99 %)
10 diff
(98.4 %id)
TI_1241112327   .a 647 to 1150 13 to 517       505/1218
(41 %)
9 diff
(99.3 %id)
TI_1241112329   .a 647 to 1156 14 to 524       511/1209
(42 %)
11 diff
(99.1 %id)
CK825929 Pancreas, Purified pancreatic islet .a 647 to 1236 594 to 5     Submitted on the opposite strand 590/594
(99 %)
1 diff
(99.9 %id)
BM689426 eye, Retina Foveal and Macular .a 651 to 951 1 to 301   fully sequenced,   301/301
(100 %)
6 diff
(98.1 %id)
BG056407 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .a 656 to 1113 465 to 9       457/466
(98 %)
9 diff
(98.1 %id)
AI246483 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 657 to 1234 578 to 2       575/580
(99 %)
13 diff
(97.8 %id)
AI963010 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 658 to 1236 591 to 13   AAA   579/579
(100 %)
7 diff
(98.8 %id)
TI_57188144   .a 659 to 1235 53 to 629   AAA   577/577
(100 %)
3 diff
(99.5 %id)
BI859179 breast, mammary adenocarcinoma, cell line .a 660 to 1235 1 to 576   AAA   576/576
(100 %)
3 diff
(99.5 %id)
BM985001 lung .a 678 to 1236 575 to 20   AAA   556/556
(100 %)
5 diff
(99.2 %id)
CA422850 cell lines, Chondrosarcoma .a 683 to 1235 571 to 19   AAA   553/553
(100 %)
2 diff
(99.7 %id)
AI199014 anaplastic oligodendroglioma, brain .a 692 to 1236 547 to 1       547/550
(99 %)
13 diff
(97.7 %id)
T85389 liver and spleen .a 694 to 970 1 to 280   fully sequenced,   280/280
(100 %)
13 diff
(95.4 %id)
AI434070 lymph node, lymphoma, follicular mixed small and largecell .a 704 to 1236 533 to 1       533/533
(100 %)
8 diff
(98.5 %id)
AI570448 anaplastic oligodendroglioma, brain .a 704 to 1236 535 to 2       534/535
(99 %)
8 diff
(98.6 %id)
BM667641 eye, fetal eyes .a 704 to 1236 551 to 19   AAA   533/533
(100 %)
2 diff
(99.7 %id)
BQ717883 sympathetic trunk .a 705 to 1236 1 to 532   AAA   532/532
(100 %)
4 diff
(99.3 %id)
AW157816 brain, frontal lobe .a 709 to 1235 534 to 8       527/542
(97 %)
11 diff
(98.0 %id)
AI160091 heart .a 710 to 1236 527 to 1       527/527
(100 %)
3 diff
(99.5 %id)
BE222983 brain, oligodendroglioma .a 710 to 1121 412 to 1       412/427
(96 %)
26 diff
(94.0 %id)
TI_57168047   .a 711 to 1236 29 to 554   AAA   526/554
(94 %)
8 diff
(98.6 %id)
BI834904 pooled pancreas and spleen .a 716 to 958 1 to 243       243/243
(100 %)
1 diff
(99.6 %id)
CN399893 embryonic stem cells, DMSO-treated H9 cellline .a 717 to 1164 1 to 448       448/448
(100 %)
2 diff
(99.6 %id)
FN138260 breast carcinoma .a 718 to 807 1 to 90       90/90
(100 %)
2 diff
(97.8 %id)
BF477734 Prostate .a 719 to 1234 534 to 19   AAA   516/517
(99 %)
3 diff
(99.5 %id)
AI334289 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 722 to 1236 515 to 1       515/515
(100 %)
4 diff
(99.3 %id)
AI962205 pooled germ cell tumors .a 725 to 887 163 to 1       163/163
(100 %)
4 diff
(97.6 %id)
BG027453 Bone, osteosarcoma, cell line .a 729 to 1236 1 to 507   AAA   507/507
(100 %)
3 diff
(99.5 %id)
AA782571 parathyroid gland, parathyroid tumor .a 740 to 1236 511 to 13   AAA   499/499
(100 %)
12 diff
(97.6 %id)
AW473479 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 746 to 1113 376 to 9       368/376
(97 %)
2 diff
(99.5 %id)
AA460681   .a 748 to 1236 492 to 6   fully sequenced,   487/492
(98 %)
2 diff
(99.6 %id)
BI262284 lymph, lymphoma, cell line .a 748 to 1183 439 to 4   fully sequenced,   436/439
(99 %)
1 diff
(99.8 %id)
BP429443   .a 749 to 1167 1 to 419       419/419
(100 %)
4 diff
(99.1 %id)
AI640817 Kidney .a 752 to 1234 490 to 8       483/490
(98 %)
1 diff
(99.8 %id)
AI143140 heart .a 755 to 1234 493 to 14   AAA   480/480
(100 %)
18 diff
(96.3 %id)
BM669661 eye, fetal eyes .a 755 to 1234 498 to 19   AAA   480/480
(100 %)
3 diff
(99.4 %id)
AA480169 colon .a 758 to 1235 482 to 5       478/482
(99 %)
9 diff
(98.2 %id)
AA480200 colon .a 758 to 1236 481 to 4       478/481
(99 %)
6 diff
(98.8 %id)
BU728257 eye, optic nerve .a 767 to 1234 486 to 19   AAA   468/468
(100 %)
2 diff
(99.6 %id)
AA454926 germinal center B cell .a 777 to 1232 476 to 21   fully sequenced, AAA   456/456
(100 %)
10 diff
(97.9 %id)
AA612748 colon, colon tumor RER+ .a 777 to 1234 460 to 3       458/460
(99 %)
4 diff
(99.2 %id)
AI368658 anaplastic oligodendroglioma, brain .a 777 to 1234 461 to 2       460/486
(94 %)
26 diff
(94.7 %id)
AI376385   .a 777 to 1236 470 to 11   AAA   460/461
(99 %)
2 diff
(99.6 %id)
AW086027 ovary, papillary serous carcinoma .a 777 to 1236 496 to 22   AAA   475/483
(98 %)
23 diff
(95.3 %id)
AJ712133 heart .a 778 to 1244 23 to 491       469/493
(95 %)
12 diff
(97.6 %id)
BM554712 duodenal adenocarcinoma, cell line, small intestine .a 779 to 1234 1 to 456   AAA   456/456
(100 %)
2 diff
(99.6 %id)
AA993794   .a 780 to 1234 474 to 20   AAA   455/483
(94 %)
19 diff
(96.1 %id)
AI885327 anaplastic oligodendroglioma, brain .a 782 to 1236 455 to 1       455/455
(100 %)
5 diff
(99.0 %id)
BF059515 pooled germ cell tumors .a 783 to 1234 452 to 1       452/452
(100 %)
2 diff
(99.6 %id)
DB535089 hippocampus .a 788 to 1236 1 to 449     Submitted on the opposite strand 449/449
(100 %)
2 diff
(99.6 %id)
AI093032 heart .a 788 to 1234 447 to 1       447/447
(100 %)
3 diff
(99.4 %id)
AW779908 Kidney .a 789 to 1234 446 to 1       446/446
(100 %)
2 diff
(99.6 %id)
AI968260 pooled germ cell tumors .a 794 to 1234 441 to 1       441/441
(100 %)
2 diff
(99.6 %id)
AI222236 pooled .a 795 to 1234 439 to 2       438/439
(99 %)
9 diff
(98.0 %id)
AI082783 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 797 to 1235 461 to 23   AAA   439/439
(100 %)
11 diff
(97.5 %id)
AI523171 aorta .a 800 to 1236 437 to 1       437/437
(100 %)
2 diff
(99.6 %id)
BF739845 Kidney .a 800 to 1236 453 to 1       453/453
(100 %)
29 diff
(93.6 %id)
BE221168 carcinoid, lung .a 804 to 1236 434 to 1       434/435
(99 %)
10 diff
(97.8 %id)
CR988175 T-Lymphocytes .a 807 to 1238 1 to 432   AAA   432/432
(100 %)
2 diff
(99.6 %id)
AA700534 parathyroid gland, parathyroid tumor .a 812 to 1121 310 to 1       310/310
(100 %)
5 diff
(98.4 %id)
AI097523 heart .a 818 to 1236 419 to 1       419/419
(100 %)
4 diff
(99.1 %id)
AI279651 lung .a 818 to 1236 419 to 1       419/419
(100 %)
48 diff
(88.6 %id)
AW002796 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 818 to 1168 423 to 71       353/423
(83 %)
0 diff
(100 %id)
BM768327 stomach .a 821 to 1234 1 to 414   AAA   414/414
(100 %)
1 diff
(99.8 %id)
AA533050 normal prostatic epithelial cells, Prostate .a 826 to 1236 436 to 26   AAA   411/477
(86 %)
9 diff
(98.2 %id)
AI245180 Kidney .a 827 to 1236 410 to 1       410/411
(99 %)
11 diff
(97.4 %id)
BG152398 brain, glioblastoma without EGFR amplification .a 831 to 1234 405 to 2       404/406
(99 %)
11 diff
(97.3 %id)
T17260   .a 833 to 1236 403 to 1       403/404
(99 %)
13 diff
(96.8 %id)
BF478225 pooled germ cell tumors .a 849 to 1121 273 to 1       273/334
(81 %)
21 diff
(93.8 %id)
BF909577 uterus_tumor .a 854 to 1160 1 to 307       307/307
(100 %)
6 diff
(98.1 %id)
AW378518 head_neck .a 855 to 1143 301 to 13       289/301
(96 %)
2 diff
(99.4 %id)
BF310244 brain, neuroblastoma .a 862 to 1236 1 to 373   AAA   373/373
(100 %)
3 diff
(99.2 %id)
AJ712147 heart .a 868 to 1244 1 to 377       377/379
(99 %)
13 diff
(96.6 %id)
BQ021772 lung, Metastatic Chondrosarcoma .a 868 to 1234 385 to 19   AAA   367/375
(97 %)
1 diff
(99.8 %id)
EC507292 Prostate .a 873 to 976 8 to 111       104/111
(93 %)
7 diff
(93.7 %id)
BU726591 eye, Retina Foveal and Macular .a 890 to 1236 366 to 20   fully sequenced, AAA   347/347
(100 %)
1 diff
(99.8 %id)
AA909104 pooled .a 896 to 1236 346 to 9       338/346
(97 %)
0 diff
(100 %id)
AA768623 germinal center B cell .a 899 to 1055 157 to 1       157/157
(100 %)
6 diff
(96.2 %id)
AA834162 Kidney, kidney tumor .a 899 to 1187 290 to 1       290/290
(100 %)
3 diff
(99.0 %id)
AI422620 Prostate .a 902 to 1189 337 to 50       288/306
(94 %)
0 diff
(100 %id)
AI538477 B-cell, chronic lymphotic leukemia .a 906 to 1232 331 to 5       327/331
(98 %)
0 diff
(100 %id)
CD251436 brain, Pituitary .a 912 to 1234 25 to 349   AAA   325/349
(93 %)
6 diff
(98.3 %id)
CR989171 T-Lymphocytes .a 916 to 1236 1 to 321   AAA   321/321
(100 %)
4 diff
(98.8 %id)
CA312015 Human Lung Epithelial cells, lung .a 917 to 1236 338 to 19   AAA   320/331
(96 %)
6 diff
(98.2 %id)
BF437425 Prostate .a 920 to 1234 322 to 8       315/330
(95 %)
0 diff
(100 %id)
BP424720 small intestine .a 921 to 1232 1 to 312     Submitted on the opposite strand 312/316
(98 %)
4 diff
(98.8 %id)
AW769623 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 923 to 1235 316 to 1       316/404
(78 %)
5 diff
(98.8 %id)
CN399892 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 933 to 1241 1 to 309       309/318
(97 %)
2 diff
(99.4 %id)
BG150208 carcinoid, lung .a 938 to 1121 184 to 1       184/184
(100 %)
2 diff
(99.0 %id)
FN116045 breast carcinoma .a 940 to 1041 100 to 1     Submitted on the opposite strand 100/100
(100 %)
2 diff
(98.0 %id)
AW087325 colon, moderately differentiated adenocarcinoma .a 945 to 1234 293 to 3       291/293
(99 %)
0 diff
(100 %id)
AI540655 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 946 to 1234 287 to 2       286/287
(99 %)
0 diff
(100 %id)
AI286053 pooled .a 949 to 1234 289 to 4       286/289
(98 %)
0 diff
(100 %id)
T83936 liver and spleen .a 954 to 1232 286 to 8   fully sequenced,   279/286
(97 %)
0 diff
(100 %id)
AA650515 lymph node, lymphoma .a 954 to 1236 286 to 4       283/286
(98 %)
0 diff
(100 %id)
FN088795 breast carcinoma .a 966 to 1051 1 to 85       85/90
(94 %)
2 diff
(97.8 %id)
AI864570 anaplastic oligodendroglioma, brain .a 968 to 1235 271 to 4       268/271
(98 %)
0 diff
(100 %id)
AI765043 Kidney .a 970 to 1236 272 to 6       267/272
(98 %)
0 diff
(100 %id)
H17133 whole brain .a 972 to 1233 274 to 11       264/274
(96 %)
0 diff
(100 %id)
AI470592 Kidney .a 975 to 1232 283 to 23   AAA   261/261
(100 %)
9 diff
(96.6 %id)
BU192559 eye, retinoblastoma .a 985 to 1232 1 to 247   AAA   247/247
(100 %)
2 diff
(99.2 %id)
BI031347 marrow .a 1006 to 1173 9 to 177       169/177
(95 %)
6 diff
(96.7 %id)
AW406182 lymph .a 1041 to 1236 7 to 202       196/230
(85 %)
2 diff
(99.2 %id)
AI686300 Prostate .a 1054 to 1234 204 to 24   AAA   181/184
(98 %)
4 diff
(97.9 %id)
AA617641 lung, lung tumor .a 1071 to 1236 167 to 2       166/167
(99 %)
0 diff
(100 %id)
AU186128 skin .a 1072 to 1235 164 to 1       164/164
(100 %)
0 diff
(100 %id)
AI053864 ovary, papillary serous carcinoma .a 1073 to 1234 183 to 22       162/199
(81 %)
0 diff
(100 %id)
AW303201 ovary, papillary serous carcinoma .a 1073 to 1236 19 to 182   AAA Submitted on the opposite strand 164/182
(90 %)
7 diff
(96.2 %id)
FN060322 breast carcinoma .a 1078 to 1184 1 to 109       109/110
(99 %)
4 diff
(96.4 %id)
BF806422 colon_ins .a 1094 to 1207 6 to 117       112/117
(95 %)
6 diff
(94.9 %id)
N91051 parathyroid gland, parathyroid tumor .a 1103 to 1241 139 to 2       138/139
(99 %)
0 diff
(100 %id)
BF341972 brain, glioblastoma with EGFR amplification .b 1 to 648 1 to 691   tiling clone,   691/1008
(68 %)
28 diff
(97.3 %id)
AI264300 Kidney .b 622 to 1090 471 to 1   tiling clone,   471/471
(100 %)
4 diff
(99.2 %id)
TI_57202423   .c 1 to 809 22 to 838       817/838
(97 %)
46 diff
(94.6 %id)
BI824336 pooled brain, lung, testis .c 10 to 809 1 to 809   tiling clone,   809/809
(100 %)
46 diff
(94.4 %id)
CD516430 White Matter .c 631 to 1427 28 to 837   tiling clone,   808/896
(90 %)
15 diff
(98.4 %id)
BQ668468 epidermoid carcinoma, cell line, salivary gland .d 1 to 965 22 to 986 Q225P L226A D227G C240W K241Q ... tiling clone,   965/986
(97 %)
22 diff
(97.8 %id)
AA135755 uterus .d 17 to 596 1 to 584       584/597
(97 %)
34 diff
(94.4 %id)
BQ652767 hepatocellular carcinoma, cell line, Liver .d 96 to 1021 1 to 924 K215X G219X Q228K D252G N259K ... AAA   924/950
(97 %)
24 diff
(97.5 %id)
BM547387 ovary (pool of 3) .d 98 to 1010 1 to 921 Q228K V243G V244G E245Q E246G ... tiling clone,   921/1139
(80 %)
18 diff
(98.5 %id)
BQ654365 hepatocellular carcinoma, cell line, Liver .d 199 to 999 95 to 901       807/903
(89 %)
34 diff
(96.3 %id)
BQ420398 embryonal carcinoma, cell line, testis .d 257 to 1071 1 to 817   tiling clone,   817/847
(96 %)
8 diff
(99.1 %id)
AA135666 uterus .d 891 to 1207 315 to 1   tiling clone,   315/316
(99 %)
5 diff
(98.5 %id)
R45970 whole brain .d 1175 to 1542 9 to 384   tiling clone, Submitted on the opposite strand 376/428
(87 %)
12 diff
(97.2 %id)
F06800 brain, total brain .e 1 to 261 1 to 261   tiling clone,   261/261
(100 %)
4 diff
(98.5 %id)
F06388 brain, total brain .e 1 to 329 1 to 330       330/330
(100 %)
4 diff
(98.8 %id)
BG289533 bladder, transitional cell papilloma, cell line .e 2 to 718 1 to 722   tiling clone,   722/902
(80 %)
12 diff
(98.7 %id)
BG113496 Bone, osteosarcoma, cell line .e 4 to 443 1 to 444       442/1015
(43 %)
10 diff
(99.1 %id)
BG024960 lymph, lymphoma, cell line .e 9 to 833 1 to 816   tiling clone,   816/834
(97 %)
26 diff
(96.9 %id)
Z46173 brain, total brain .e 10 to 350 1 to 340       340/340
(100 %)
5 diff
(98.6 %id)
T81553 liver and spleen .e 10 to 296 1 to 286       286/286
(100 %)
5 diff
(98.3 %id)
R50188 breast .e 11 to 371 1 to 363       363/363
(100 %)
7 diff
(98.1 %id)
F05562 brain, total brain .e 18 to 272 1 to 254       254/254
(100 %)
8 diff
(96.9 %id)
R50134 breast .e 717 to 1032 315 to 1   tiling clone,   315/323
(97 %)
6 diff
(98.2 %id)
Z41802 brain, total brain .e 755 to 1031 277 to 1   tiling clone,   277/277
(100 %)
1 diff
(99.7 %id)
F02680 brain, total brain .e 758 to 1033 276 to 1   tiling clone,   276/276
(100 %)
1 diff
(99.7 %id)
F03063 brain, total brain .e 759 to 1033 275 to 1       275/275
(100 %)
1 diff
(99.7 %id)
T81976 liver and spleen .e 760 to 1026 278 to 12       267/278
(96 %)
0 diff
(100 %id)
F01829 brain, total brain .e 815 to 1033 219 to 1       219/219
(100 %)
1 diff
(99.6 %id)
BQ054206 blood, natural killer cells, cell line .f 1 to 960 1 to 968 N152K Q169K V185G E186P E187X ... tiling clone,   968/998
(96 %)
25 diff
(97.5 %id)
BI829839 brain, medulla .f 36 to 755 1 to 718   tiling clone,   718/718
(100 %)
5 diff
(99.4 %id)
TI_57176405   .f 36 to 755 68 to 785       718/785
(91 %)
9 diff
(98.9 %id)
BG911285 anaplastic oligodendroglioma with 1p/19qloss, brain .g 1 to 789 10 to 793 Q146S L148S I149S F150S H151T ... tiling clone,   784/794
(98 %)
21 diff
(97.4 %id)
CR995726 T-Lymphocytes .g 145 to 772 1 to 628   tiling clone,   628/628
(100 %)
0 diff
(100 %id)
BM478628 embryonal carcinoma, cell line, testis .h 1 to 735 1 to 744 Q105K A154V N157K Q159R Q162R ... tiling clone,   744/1081
(68 %)
37 diff
(96.6 %id)
CR993650 T-Lymphocytes .i 1 to 632 1 to 632 Q112K tiling clone,   632/635
(99 %)
2 diff
(99.7 %id)
CT002654 T-Lymphocytes .j-u 1 to 650 1 to 650 exact tiling clone,   650/653
(99 %)
1 diff
(99.9 %id)
DB498231 hypothalamus Gene AIP, variant not shown         This clone was ignored    
DB569326 hypothalamus Gene AIP, variant not shown         Submitted on the opposite strand    
DB561871 hypothalamus Gene AIP, variant not shown         Submitted on the opposite strand    
AW975906   Gene AIP, variant not shown         Submitted on the opposite strand    
AW957928   Gene AIP, variant not shown         This clone was ignored    
AA327568 colon Gene AIP, variant not shown         This clone was ignored    
R25265 whole brain Gene AIP, variant not shown         This clone was ignored    
R46618 whole brain Gene AIP, variant not shown         This clone was ignored    
AI026016 parathyroid gland, parathyroid tumor Gene AIP, variant not shown         This clone was ignored    
AI025660 parathyroid gland, parathyroid tumor Gene AIP, variant not shown         Suspected internal deletion, this clone was ignored    
AI126818 heart Gene AIP, variant not shown         This clone was ignored    
AW157435 brain, frontal lobe Gene AIP, variant not shown         Suspected internal deletion, this clone was ignored    
AW163497 brain, frontal lobe Gene AIP, variant not shown         Suspected internal deletion, this clone was ignored    
BF514022   Gene AIP, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BG031693 breast, mammary adenocarcinoma, cell line Gene AIP, variant not shown         Suspected internal deletion, this clone was ignored    
BG706315 brain, hypothalamus Gene AIP, variant not shown       AAA This clone was ignored    
BI599981 brain, hypothalamus Gene AIP, variant not shown       AAA This clone was ignored    
BM467159 eye, retinoblastoma Gene AIP, variant not shown         Suspected internal deletion, this clone was ignored    
TI_45215628   Gene AIP, variant not shown       AAA This clone was ignored    
TI_182940334   Gene AIP, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI